Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DSM-Firmenich AGDSMFF 57 Cash Ratio is 0.34 as of Dec. 2025, which is 40% below its 10-year median of 0.57. GuruFocus rates DSMFF with a GF Score™ of 57/100 and a GF Value™ of $89.10 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,581 Chemicals companies, DSM-Firmenich AG ranks worse than 61.35% on this metric.
DSM-Firmenich AG has a Cash Ratio of 0.34. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for DSM-Firmenich AG's Cash Ratio or its related term are showing as below:
DSMFF'
s Cash Ratio Range Over the Past 10 Years
Min: 0.34 Med: 0.57 Max: 0.62
Current: 0.34
During the past 4 years, DSM-Firmenich AG's highest Cash Ratio was 0.62. The lowest was 0.34. And the median was 0.57.
DSMFF's Cash Ratio is ranked worse than 61.35% of 1581
companies
in the Chemicals industry
Industry Median: 0.5
vs DSMFF: 0.34
DSM-Firmenich AG (OTCPK:DSMFF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
DSM-Firmenich AG Cash Ratio Related Terms
DSM-Firmenich AG Cash Ratio Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, DSM-Firmenich AG's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG Cash Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's Cash Ratio distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (DSMFF) has a Cash Ratio of 0.34 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on DSM-Firmenich AG and its competitors. This is 40% below median its historical median of 0.57. Over the past decade, DSM-Firmenich AG's Cash Ratio has ranged from 0.34 to 0.62. According to the industry distribution chart, DSM-Firmenich AG ranks #970 out of 1581 companies in the Chemicals industry, placing it in the top 61.4%.
Is DSM-Firmenich AG's Cash Ratio too high?
DSM-Firmenich AG's current Cash Ratio of 0.34 is 40% below median its 10-year median of 0.57. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 0.62. The Chemicals industry median Cash Ratio is 0.50. DSM-Firmenich AG's value of 0.34 is 32% below this industry median. Based on the distribution chart, DSM-Firmenich AG ranks #970 out of 1581 companies in the Chemicals industry, which is below the industry midpoint. Overall, DSM-Firmenich AG has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's Cash Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #970 out of 1581 companies for Cash Ratio. This places DSM-Firmenich AG in the lower half of its industry. The industry median Cash Ratio is 0.50. DSM-Firmenich AG's value of 0.34 is 32% below this benchmark. Historically, DSM-Firmenich AG's own Cash Ratio has ranged from 0.34 to 0.62 over the past decade. While the company's 10-year median is 0.57 vs. the industry median of 0.50, DSM-Firmenich AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Chemicals company?
The median Cash Ratio among Chemicals companies is 0.50, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DSM-Firmenich AG's current Cash Ratio of 0.34 is 32% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on DSM-Firmenich AG and its competitors. For the Chemicals industry, the median Cash Ratio is 0.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current Cash Ratio is 0.34, which is 40% below median its own 10-year median of 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (DSMFF) is currently considered Fairly Valued. The stock's GF Value™ is $89.10, compared to a current price of $91.31 — trading 2.5% above its estimated fair value. The current Cash Ratio is 0.34, which is 40% below median its 10-year median of 0.57 and 32% below the Chemicals industry median of 0.50. DSM-Firmenich AG's overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For DSM-Firmenich AG (DSMFF), the current Cash Ratio is 0.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (DSMFF) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of $91.31 is trading 2.5% above its estimated GF Value™ of $89.10.
GuruFocus considers DSM-Firmenich AG to be Fairly Valued.
Key valuation signals for DSMFF:
Cash Ratio: 0.34 (40% below median its 10-year median of 0.57)
GF Value™: $89.10 vs. price of $91.31 (2.5% above fair value)
Industry Position: 32% below the Chemicals median (#970 of 1581)
No single metric tells the full story. See the DSMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
57GF Score
Get the complete analysis for DSMFF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSMFF has been successfully added to your 
